111 related articles for article (PubMed ID: 2435271)
21. Detection of myelin basic protein-like material in cerebrospinal fluid of multiple sclerosis patients by immunoblot assay.
Losy J; Mehta PD
J Neurol Sci; 1990 Nov; 99(2-3):321-6. PubMed ID: 1707953
[TBL] [Abstract][Full Text] [Related]
22. Radioimmunoassay of myelin basic protein in cerebrospinal fluid and its clinical application to patients with neurological diseases.
Ohta M; Matsubara F; Konishi T; Nishitani H
Life Sci; 1980 Sep; 27(12):1069-74. PubMed ID: 6158639
[No Abstract] [Full Text] [Related]
23. Myelin basic protein in CSF and blood. Relationship between its presence and the occurrence of a destructive process in the brains of encephalitic patients.
Jacque C; Delassalle A; Rancurel G; Raoul M; Lesourd B; Legrand JC
Arch Neurol; 1982 Sep; 39(9):557-60. PubMed ID: 6180715
[TBL] [Abstract][Full Text] [Related]
24. [Myelin basic protein in cerebrospinal fluid in neurocysticercosis].
Livramento JA; Machado LR; Whitaker JN; Spina-Franca A
Arq Neuropsiquiatr; 1985 Jun; 43(2):160-6. PubMed ID: 2415091
[TBL] [Abstract][Full Text] [Related]
25. Concentration of myelin basic protein in cerebrospinal fluid in prognosis of multiple sclerosis.
Matias-Guiu J; Ruibal A; Martinez-Vazquez JM; Colomer R; Codina A
Clin Chem; 1986 May; 32(5):915-6. PubMed ID: 2421947
[No Abstract] [Full Text] [Related]
26. Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination.
Cohen SR; Herndon RM; McKhann GM
N Engl J Med; 1976 Dec; 295(26):1455-7. PubMed ID: 995142
[TBL] [Abstract][Full Text] [Related]
27. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
Warren KG; Catz I
Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
[TBL] [Abstract][Full Text] [Related]
28. Myelin basic protein in the cerebrospinal fluid of patients infected with HIV.
Pfister HW; Einhäupl KM; Wick M; Fateh-Moghadam A; Huber M; Schielke E; Goebel FD; Matuschke A; Heinrich B; Bogner JR
J Neurol; 1989 Jul; 236(5):288-91. PubMed ID: 2474637
[TBL] [Abstract][Full Text] [Related]
29. Neutralization of anti-myelin basic protein by cerebrospinal fluid of multiple sclerosis patients in clinical remission.
Warren KG; Catz I
J Neurol Sci; 1988 Dec; 88(1-3):185-94. PubMed ID: 2465390
[TBL] [Abstract][Full Text] [Related]
30. Comparison of a non-competitive two-site RIA and an inhibition RIA for the detection of myelin basic protein in cerebrospinal fluid.
Nagelkerken LM; Van Zoonen-Van Exel M; Aalberse RC; Van Walbeek HK; Out TA
J Neuroimmunol; 1983 Oct; 5(2):157-70. PubMed ID: 6194179
[TBL] [Abstract][Full Text] [Related]
31. A correlation between cerebrospinal fluid myelin basic protein and anti-myelin basic protein in multiple sclerosis patients.
Warren KG; Catz I
Ann Neurol; 1987 Feb; 21(2):183-9. PubMed ID: 2435224
[TBL] [Abstract][Full Text] [Related]
32. [Determination of myelin basic protein in the cerebrospinal fluid in neurologic diseases].
Bürgisser P; Matthieu JM; de Tribolet N; Gautier E
Schweiz Med Wochenschr; 1982 May; 112(18):643-7. PubMed ID: 6177033
[TBL] [Abstract][Full Text] [Related]
33. Research approaches on the diagnosis of multiple sclerosis by CSF examination.
Schmidt RM; Kuppe G; Kissig B; Ludewig R; Neumann V
Schweiz Arch Neurol Psychiatr (1985); 1987; 138(3):13-22. PubMed ID: 2441464
[TBL] [Abstract][Full Text] [Related]
34. Detection of myelin basic protein in cerebrospinal fluid and serum from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Ohta M; Ohta K; Nishimura M; Saida T
Ann Clin Biochem; 2002 Nov; 39(Pt 6):603-5. PubMed ID: 12564844
[TBL] [Abstract][Full Text] [Related]
35. Plasma exchange of malignant multiple sclerosis.
Warren KG; Gordon PA; McPherson TA
Can J Neurol Sci; 1982 Feb; 9(1):27-30. PubMed ID: 6178490
[TBL] [Abstract][Full Text] [Related]
36. A double antibody radioimmunoassay for myelin basic protein in cerebrospinal fluid.
McPherson TA; Catz I
Clin Biochem; 1985 Oct; 18(5):297-9. PubMed ID: 2414034
[TBL] [Abstract][Full Text] [Related]
37. The relationship between levels of cerebrospinal fluid myelin basic protein and IgG measurements in patients with multiple sclerosis.
Warren KG; Catz I
Ann Neurol; 1985 May; 17(5):475-80. PubMed ID: 2408558
[TBL] [Abstract][Full Text] [Related]
38. Indicators of disease activity in multiple sclerosis. Studies of myelin basic protein-like materials.
Whitaker JN
Ann N Y Acad Sci; 1984; 436():140-50. PubMed ID: 6085224
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.
Jongen PJ; Lamers KJ; Doesburg WH; Lemmens WA; Hommes OR
J Neurol Neurosurg Psychiatry; 1997 Oct; 63(4):446-51. PubMed ID: 9343121
[TBL] [Abstract][Full Text] [Related]
40. The short-term effect of an immunosuppressive treatment on CSF myelin basic protein in chronic progressive multiple sclerosis.
Lamers KJ; Uitdehaag BM; Hommes OR; Doesburg W; Wevers RA; von Geel WJ
J Neurol Neurosurg Psychiatry; 1988 Oct; 51(10):1334-7. PubMed ID: 2465387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
